116 related articles for article (PubMed ID: 30807822)
1. Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group.
Esiashvili N; Lu X; Ulin K; Laurie F; Kessel S; Kalapurakal JA; Merchant TE; Followill DS; Sathiaseelan V; Schmitter MK; Devidas M; Chen Y; Wall DA; Brown PA; Hunger SP; Grupp SA; Pulsipher MA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):513-521. PubMed ID: 30807822
[TBL] [Abstract][Full Text] [Related]
2. Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.
Belkacémi Y; Pène F; Touboul E; Rio B; Leblond V; Gorin NC; Laugier A; Gemici C; Housset M; Ozsahin M
Strahlenther Onkol; 1998 Feb; 174(2):92-104. PubMed ID: 9487372
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic Pneumonitis Syndrome After Total Body Irradiation in Pediatric Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation: A PENTEC Comprehensive Review.
Ehler ED; Turcotte LM; Skamene S; Baker KS; Das SK; Constine LS; Yuan J; Dusenbery KE
Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):625-639. PubMed ID: 36973099
[TBL] [Abstract][Full Text] [Related]
4. Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia.
Tracey J; Zhang MJ; Thiel E; Sobocinski KA; Eapen M
Biol Blood Marrow Transplant; 2013 Feb; 19(2):255-9. PubMed ID: 23041605
[TBL] [Abstract][Full Text] [Related]
5. Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Battipaglia G; Labopin M; Mielke S; Ruggeri A; Nur Ozkurt Z; Bourhis JH; Rabitsch W; Yakoub-Agha I; Grillo G; Sanz J; Arcese W; Novis Y; Fegueux N; Spyridonidis A; Giebel S; Nagler A; Ciceri F; Mohty M
Transplant Cell Ther; 2024 Jan; 30(1):95.e1-95.e10. PubMed ID: 37816471
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
Satwani P; Sather H; Ozkaynak F; Heerema NA; Schultz KR; Sanders J; Kersey J; Davenport V; Trigg M; Cairo MS
Biol Blood Marrow Transplant; 2007 Feb; 13(2):218-27. PubMed ID: 17241927
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive comparison between TBI vs non-TBI-based conditioning regimen in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis.
Ansari F; Behfar M; Jafari L; Mohseni R; Naji P; Karamlou Y; Amirzade-Iranaq MH; Hamidieh AA
Leuk Res; 2023 Dec; 135():107416. PubMed ID: 37918224
[TBL] [Abstract][Full Text] [Related]
8. The paradigm of total body irradiation in acute lymphoblastic leukaemia: Therapeutic effectiveness versus the challenges of toxicity.
Echecopar C; Del Val Rey I; Galán-Gómez V; González-Pérez C; Mozo Del Castillo Y; González Martínez B; Pérez-Martínez A
An Pediatr (Engl Ed); 2024 Apr; 100(4):259-267. PubMed ID: 38548564
[TBL] [Abstract][Full Text] [Related]
9. TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.
Ueki H; Ogawa C; Goto H; Nishi M; Yamanaka J; Mochizuki S; Nishikawa T; Kumamoto T; Nishiuchi R; Kikuta A; Yamamoto S; Igarashi S; Sato A; Hori T; Saito AM; Watanabe T; Deguchi T; Manabe A; Horibe K; Toyoda H
Int J Hematol; 2024 Apr; 119(4):450-458. PubMed ID: 38267673
[TBL] [Abstract][Full Text] [Related]
10. Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Hui S; Brunstein C; Takahashi Y; DeFor T; Holtan SG; Bachanova V; Wilke C; Zuro D; Ustun C; Weisdorf D; Dusenbery K; Verneris MR
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1110-1116. PubMed ID: 28396164
[TBL] [Abstract][Full Text] [Related]
11. Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease.
Eapen M; Brazauskas R; Williams DA; Walters MC; St Martin A; Jacobs BL; Antin JH; Bona K; Chaudhury S; Coleman-Cowger VH; DiFronzo NL; Esrick EB; Field JJ; Fitzhugh CD; Kanter J; Kapoor N; Kohn DB; Krishnamurti L; London WB; Pulsipher MA; Talib S; Thompson AA; Waller EK; Wun T; Horowitz MM
J Clin Oncol; 2023 Apr; 41(12):2227-2237. PubMed ID: 36623245
[TBL] [Abstract][Full Text] [Related]
12. Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease.
Imamura M
Cytotherapy; 2023 Dec; 25(12):1251-1258. PubMed ID: 37665303
[TBL] [Abstract][Full Text] [Related]
13. Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia.
Mora E; Montoro J; Balaguer A; Rovira M; Cabrero M; Heras I; Ribera JM; Antelo G; Martin AA; Lopez Godino O; Torrent A; Villalba M; Chorao P; Sanz MA; Sanz J;
Bone Marrow Transplant; 2024 May; ():. PubMed ID: 38755458
[TBL] [Abstract][Full Text] [Related]
14. Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions.
Hoeben BAW; Wong JYC; Fog LS; Losert C; Filippi AR; Bentzen SM; Balduzzi A; Specht L
Front Pediatr; 2021; 9():774348. PubMed ID: 34926349
[TBL] [Abstract][Full Text] [Related]
15. Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation.
Baker KS; Leisenring WM; Goodman PJ; Ermoian RP; Flowers ME; Schoch G; Storb R; Sandmaier BM; Deeg HJ
Blood; 2019 Jun; 133(26):2790-2799. PubMed ID: 30992266
[TBL] [Abstract][Full Text] [Related]
16. Conditioning Regimen in Patients With Adult Acute B Lymphoblastic Leukemia.
Shibusawa M; Tanimoto T
J Clin Oncol; 2023 Mar; 41(7):1496-1497. PubMed ID: 36595732
[No Abstract] [Full Text] [Related]
17. Growth impairment after TBI of leukemia survivors children: a model- based investigation.
Galletto C; Gliozzi A; Nucera D; Bertorello N; Biasin E; Corrias A; Chiabotto P; Fagioli F; Guiot C
Theor Biol Med Model; 2014 Oct; 11():44. PubMed ID: 25312098
[TBL] [Abstract][Full Text] [Related]
18. Body composition after allogeneic haematopoietic cell transplantation/total body irradiation in children and young people: a restricted systematic review.
Lorenc A; Hamilton-Shield J; Perry R; Stevens M;
J Cancer Surviv; 2020 Oct; 14(5):624-642. PubMed ID: 32388841
[TBL] [Abstract][Full Text] [Related]
19. Radiation-free conditioning in acute lymphoblastic leukemia: is it time?
Espinoza-Gutarra M; Mohty R; Jamy O
Chin Clin Oncol; 2024 Apr; 13(2):29. PubMed ID: 38372061
[No Abstract] [Full Text] [Related]
20. Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation.
Dogliotti I; Levis M; Martin A; Bartoncini S; Felicetti F; Cavallin C; Maffini E; Cerrano M; Bruno B; Ricardi U; Giaccone L
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
